Drug
Epinephrine Nasal Spray
Epinephrine Nasal Spray: highest development phase Phase 2, developed by Hikma. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Hikma
Trials
| Drug | Phase | Indication |
|---|---|---|
| Epinephrine Nasal Spray, 2.5 mg NCT07891780 | Phase 2 | Epinephrine |
Latest
No recent events.
Follow Epinephrine Nasal Spray on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.